Healthcare
The delivery of healthcare continues to evolve at a rapid pace, creating both challenges and opportunities throughout the industry. Our clients rely on us to help them navigate complex legal and reimbursement requirements so they can do what they do best—provide top-level care to patients. We strive to offer that same level of care and service to our clients.
We represent a broad spectrum of healthcare entities, including hospitals and health systems, senior living and skilled nursing facilities, ambulatory surgery center, and physician groups, regarding federal and state legal issues. Our years of experience within the healthcare industry provide us with an acute understanding of providers and the related businesses that comprise the healthcare system.
We counsel clients on matters unique to the healthcare industry, as well as the broader corporate, tax, employment, and regulatory matters that all U.S. businesses face today.
Our services include:
- Antitrust
- Certificate of need
- Corporate organization and governance
- Enforcement and investigations
- False Claims Act litigation
- Financing and restructuring
- Fraud and abuse
- Health information privacy and security
- Managed care
- Medicare and Medicaid reimbursement
- Medical staff matters
- Mergers, acquisitions, and joint ventures
- Regulatory compliance
- Telehealth
Related
Practices
Ambulatory Surgery CentersAntitrust and Trade RegulationEmployee Benefits and Executive CompensationGovernment Investigations and Corporate ComplianceHealthcare Administrative Law and Regulatory AppealsHIPAA - Health Information Privacy and SecurityHospitals and Health SystemsIntellectual PropertyLabor and EmploymentLong-Term and Post-Acute Care ProvidersNonprofits and Tax-Exempt OrganizationsPharmacies and Drug ControlPhysicians, Dentists, and Non-Physician PractitionersData Privacy and Cybersecurity Real EstateRestructuring and BankruptcyTaxTechnology and Sourcing Transactions
The Doctor Will Stream You Now: DEA’s Proposed Telemedicine Framework
On January 17, 2025, the U.S. Drug Enforcement Administration (“DEA”) published a notice of proposed…
Dykema M&A Volume Remains Strong During Another Challenging Year
We entered 2024 hoping that some of the uncertainties impacting the M&A market would recede into the…
Supreme Court Allows CTA Enforcement, but Questions Remain
On January 23, 2025, the U.S. Supreme Court granted the Secretary of the Treasury’s application to…
